1
|
Durán Giménez-Rico H, Diéguez Aguirre L, Ríos Pérez L, Cardinal-Fernández P, Caruso R, Ferri V, Quijano Collazo Y, Vicente López E. Comparative study between total and subtotal gastrectomy for distal gastric cancer: Meta-analysis of prospective and retrospective studies. Cir Esp 2020; 98:582-590. [PMID: 32600642 DOI: 10.1016/j.ciresp.2020.05.028] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/01/2020] [Revised: 05/15/2020] [Accepted: 05/18/2020] [Indexed: 12/30/2022]
Abstract
There is no clear agreement on the type of gastrectomy to be used (either total [TG] or distal [DG]) in middle or distal gastric cancer, especially when it is undifferentiated or Lauren diffuse type. In this meta-analysis, we intend to define which of the 2techniques should be recommended, based on survival, morbidity and mortality rates. Prospective and retrospective studies comparing both techniques have been included for a total of 6303 patients (3,641 DG and 2,662 TG). DG was significantly associated with fewer complications, fewer anastomotic fistulae, and less perioperative mortality. The number of lymph nodes in DG was significantly lower, but always above 15. Finally, even the 5-year survival of DG was also higher. Therefore, DG, as long as a safety margin is obtained and regardless of the histological type, should be performed in surgery for distal stomach cancer.
Collapse
Affiliation(s)
- Hipólito Durán Giménez-Rico
- Servicio de Cirugía General, Departamento de Ciencias Médicas Clínicas (Sección de Cirugía), Hospital Universitario HM Sanchinarro, Universidad San Pablo CEU, Madrid, España; Fundación para el Desarrollo e Investigación de Cirugía Oncológica, Madrid, España.
| | - Lucía Diéguez Aguirre
- Servicio de Cirugía General, Departamento de Ciencias Médicas Clínicas (Sección de Cirugía), Hospital Universitario HM Sanchinarro, Universidad San Pablo CEU, Madrid, España
| | - Lucía Ríos Pérez
- Servicio de Cirugía General, Departamento de Ciencias Médicas Clínicas (Sección de Cirugía), Hospital Universitario HM Sanchinarro, Universidad San Pablo CEU, Madrid, España
| | | | - Riccardo Caruso
- Servicio de Cirugía General, Departamento de Ciencias Médicas Clínicas (Sección de Cirugía), Hospital Universitario HM Sanchinarro, Universidad San Pablo CEU, Madrid, España; Fundación para el Desarrollo e Investigación de Cirugía Oncológica, Madrid, España
| | - Valentina Ferri
- Servicio de Cirugía General, Departamento de Ciencias Médicas Clínicas (Sección de Cirugía), Hospital Universitario HM Sanchinarro, Universidad San Pablo CEU, Madrid, España; Fundación para el Desarrollo e Investigación de Cirugía Oncológica, Madrid, España
| | - Yolanda Quijano Collazo
- Servicio de Cirugía General, Departamento de Ciencias Médicas Clínicas (Sección de Cirugía), Hospital Universitario HM Sanchinarro, Universidad San Pablo CEU, Madrid, España; Fundación para el Desarrollo e Investigación de Cirugía Oncológica, Madrid, España; Cátedra Internacional de Investigación en Cirugía General y Digestiva, Universidad Católica de Murcia, Murcia, España
| | - Emilio Vicente López
- Servicio de Cirugía General, Departamento de Ciencias Médicas Clínicas (Sección de Cirugía), Hospital Universitario HM Sanchinarro, Universidad San Pablo CEU, Madrid, España; Fundación para el Desarrollo e Investigación de Cirugía Oncológica, Madrid, España; Cátedra Internacional de Investigación en Cirugía General y Digestiva, Universidad Católica de Murcia, Murcia, España
| |
Collapse
|
2
|
Loinaz Segurola C, Ochando Cerdán F, Vicente López E, Serrablo Requejo A, López Cillero P, Gómez Bravo MÁ, Fabregat Prous J, Varo Pérez E, Miyar de León A, Fondevila Campo C, Valdivieso López A, Blanco Fernández G, Sánchez B, López Andújar R, Fundora Suárez Y, Cugat Andorra E, Díez Valladares L, Herrera Cabezón J, García Gil A, Morales Soriano R, Pardo Sánchez F, Sabater Ortí L, López Baena JÁ, Muñoz Bellvís L, Martín Pérez E, Pérez Saborido B, Suárez Muñoz MÁ, Meneu Día JC, Albiol Quer M, Sanjuanbenito Dehesa A, Ramia Ángel JM, Pereira Pérez F, Paseiro Crespo G, Palomo Sánchez JC, León Sanz M. Results of a survey on peri-operative nutritional support in pancreatic and biliary surgery in Spain. NUTR HOSP 2020; 37:238-242. [PMID: 32090583 DOI: 10.20960/nh.02895] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/07/2023] Open
Abstract
Introduction: a survey on peri-operative nutritional support in pancreatic and biliary surgery among Spanish hospitals in 2007 showed that few surgical groups followed the 2006 ESPEN guidelines. Ten years later we sent a questionnaire to check the current situation. Methods: a questionnaire with 21 items sent to 38 centers, related to fasting time before and after surgery, nutritional screening use and type, time and type of peri-operative nutritional support, and number of procedures. Results: thirty-four institutions responded. The median number of pancreatic resections (head/total) was 29.5 (95% CI: 23.0-35; range, 5-68) (total, 1002); of surgeries for biliary malignancies (non-pancreatic), 9.8 (95% CI: 7.3-12.4; range, 2-30); and of main biliary resections for benign conditions, 10.4 (95% CI: 7.6-13.3; range, 2-33). Before surgery, only 41.2% of the sites used nutritional support (< 50% used any nutritional screening procedure). The mean duration of preoperative fasting for solid foods was 9.3 h (range, 6-24 h); it was 6.6 h for liquids (range, 2-12). Following pancreatic surgery, 29.4% tried to use early oral feeding, but 88.2% of the surveyed teams used some nutritional support; 26.5% of respondents used TPN in 100% of cases. Different percentages of TPN and EN were used in the other centers. In malignant biliary surgery, 22.6% used TPN always, and EN in 19.3% of cases. Conclusions: TPN is the commonest nutrition approach after pancreatic head surgery. Only 29.4% of the units used early oral feeding, and 32.3% used EN; 22.6% used TPN regularly after surgery for malignant biliary tumours. The 2006 ESPEN guideline recommendations are not regularly followed 12 years after their publication in our country.
Collapse
|
3
|
Navarro EB, López EV, Quijano Y, Caruso R, Ferri V, Durand H, Cabrera IF, Reques ED, Ielpo B, Glagolieva AY, Plaza C. Impact of BRCA1/2 gene mutations on survival of patients with pancreatic cancer: A case-series analysis. Ann Hepatobiliary Pancreat Surg 2019; 23:200-205. [PMID: 31225426 PMCID: PMC6558134 DOI: 10.14701/ahbps.2019.23.2.200] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 09/03/2018] [Revised: 12/10/2018] [Accepted: 12/14/2018] [Indexed: 12/19/2022] Open
Abstract
BRCA gene mutations are found in up to 10% of pancreatic adenocarcinoma cases. We present a description of 4 cases along with a review of the current literature regarding pathogenesis, target treatment, response and survival rates in these types of malignancies. We describe four cases of pancreatic adenocarcinoma, in three of which the BRCA2 mutation was identified, in one - BRCA1 gene alteration. Two patients underwent surgery following the neoadjuvant treatment with Folfirinox and radiotherapy; in the first case, a distal pancreatectomy with splenectomy was performed and in the second one - the Whipple's procedure. In both cases, a complete pathological response was reported. Other 2 patients were treated with Folfirinox after BRCA mutation identification and acceptable life expectancy was obtained. The association of pathologic complete response (PCR) with lower rates of local recurrence and better survival in patients with various types of adenocarcinomas is well known. Identification of such patients carrying BRCA mutations could provide an application of better personalized treatment. In some patients with pancreatic cancer, especially when there is clinical or demographic reason to suspect a genetic predisposition, a confirmation of the presence of BRCA mutations could provide an opportunity to use target treatment with beneficial outcomes regarding survival.
Collapse
Affiliation(s)
- Ernesto Barzola Navarro
- Department of General and Digestive Surgery, Hospital Universitario Madrid Sanchinarro, Madrid, Spain
| | - Emilio Vicente López
- Department of General and Digestive Surgery, Hospital Universitario Madrid Sanchinarro, Madrid, Spain
| | - Yolanda Quijano
- Department of General and Digestive Surgery, Hospital Universitario Madrid Sanchinarro, Madrid, Spain
| | - Riccardo Caruso
- Department of General and Digestive Surgery, Hospital Universitario Madrid Sanchinarro, Madrid, Spain
| | - Valentina Ferri
- Department of General and Digestive Surgery, Hospital Universitario Madrid Sanchinarro, Madrid, Spain
| | - Hipolito Durand
- Department of General and Digestive Surgery, Hospital Universitario Madrid Sanchinarro, Madrid, Spain
| | - Isabel Fabra Cabrera
- Department of General and Digestive Surgery, Hospital Universitario Madrid Sanchinarro, Madrid, Spain
| | - Eduardo Diaz Reques
- Department of General and Digestive Surgery, Hospital Universitario Madrid Sanchinarro, Madrid, Spain
| | - Benedetto Ielpo
- Department of General and Digestive Surgery, Hospital Universitario Madrid Sanchinarro, Madrid, Spain
| | | | - Carlos Plaza
- Department of Pathology, Hospital Universitario Madrid Sanchinarro, Madrid, Spain
| |
Collapse
|
4
|
López EV, Burgos Florez J, Alvarez Caperochipi J, Enriquez Valens P, Pagazaurtundua Gómez S, Hernández Fernández C. [Hepatic hydatidosis: diagnostic and therapeutic aspects. Apropos of 100 cases]. Rev Esp Enferm Apar Dig 1982; 62:217-23. [PMID: 7178631] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 01/23/2023]
|